News

Nidhi's paper on plasma vs tau PET is out!

By Jhony Mejia on September 25, 2023
Nidhi Mundada conducted a head to head comparison of plama p-tau217 with Flortaucipir PET in amyloid-positive subjects with cognitive impairment. Blood assessments were acquired within 1 year from the tau PET.

Cho et al. out on Alz&Dem

By Jhony Mejia on September 18, 2023
Hanna Cho describes the baseline cross-sectional data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS) cohort. All subjects were younger than 65 years old.

Gil featured on NeurologyToday in a post about Donanemab

By Jhony Mejia on September 07, 2023
Gil is featured on a NeurologyToday post about donanemab and the next steps after positive results of the phase 3 trial.

Gil featured in a Washington Post about Alzheimer's treatments

By Jhony Mejia on July 05, 2023
Gil is featured on a new Washington post about emerging treatments for Alzheimer's Disease.

Gil comments on blood tests for Alzheimer's on UCSF magazine

By Jhony Mejia on June 29, 2023
A new post from UCSF magazine features Gil and other UCSF professors giving their insights on emerging blood tests for Alzheimer's Disease.

Marianne awarded the Alavi-Mandell Award

By Jhony Mejia on May 25, 2023
We congratulate Marianne Chapleau for receiving the Alavi-Mandell Award for her publication “The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review”. The award is given to individuals who were the first author of a paper published in the JNM, were trainees at the time the...

Hiring at post-baccalaureate level

By Jhony Mejia on May 02, 2023
We are hiring a full-time Data Analyst! It is a junior-level, post-baccalaureate research position. Ideal for recent bachelors looking to gain more research experience. We prefer a minimum 2-year commitment, with many Data Analysts moving on to top graduate programs and medical schools.

Gil featured on The Washington Post

By Jhony Mejia on April 27, 2023
Gil Rabinovici contributes to an article describing the struggles of people affected by early-stage Alzheimer's Disease, how they cope with those difficulties, and how medications might factor in. Inspiring piece highlighting the motivation for all the research we do at RabLab.

RabLab at HAI2023!

By Jhony Mejia on January 27, 2023
HAI2023 returned to in-person format in Miami - and we were there! Presentations Marianne Chapleau Association of FDG-PET with co-pathologies in autopsy-proven AD  

RabLab at AAIC2022!

By Jhony Mejia on October 28, 2022
We are back to in person conferences! Had an amazing time in San Diego at AAIC2022 Presentations Gil D Rabinovici ALZ-NET: Using Real World Evidence to Inform the Future of Alzheimer's Treatment and Care

Pages